Imagion Initiates Manufacturing of Drug for Phase 2 Study
Filed with ASX · · 2 pages · English
Imagion Biosystems Ltd. on 6ix
Earlier from Imagion Biosystems
- Quarterly Activities/Appendix 4C Cash Flow Report
- Successful Placement of A$3M
- Response to ASX Price Query
- Half Yearly Report and Accounts
- Variation of Convertible Securities Agreement
Later from Imagion Biosystems
- Appendix 4E and 2024 Financial Report
- Appendix 4C and Quarterly Activities Report - March 2025
- Imagion Receive Positive FDA Feedback for HER2 Phase 2 Trial
- Imagion MagSense Breast Cancer Program Phase 2 Trial Update
- Appendix 4C and Quarterly Activities Report - June 2025
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems